top of page

Management of Rhinosinusitis (Sinusitis): Stepwise Approach from First Stage to Antibiotic Therapy

1. Definition and Classification

Rhinosinusitis refers to inflammation of the mucosa of the nasal cavity and paranasal sinuses.It often begins as viral rhinosinusitis and may progress to bacterial sinusitis in a small percentage of cases.

Type

Duration

Typical Cause

Acute

≤ 4 weeks

Usually viral; bacterial if severe/persistent

Subacute

4–12 weeks

Unresolved infection

Chronic

> 12 weeks

Multifactorial (inflammation, allergy, biofilm, polyp)


2. Common Etiologic Agents

Viral (Most Common, ~90%)

  • Rhinovirus, Influenza, Parainfluenza, Coronavirus

Bacterial (Secondary infection)

  • Streptococcus pneumoniae

  • Haemophilus influenzae

  • Moraxella catarrhalis

3. Diagnostic Criteria: When to Suspect Bacterial Sinusitis

Antibiotics are NOT first-line for all sinusitis.They are reserved for bacterial cases based on these IDSA criteria:

Acute Bacterial Rhinosinusitis (ABRS) criteria

At least one of the following:

  1. Persistent symptoms > 10 days without improvement

  2. Severe symptoms: high fever ≥ 39 °C + purulent nasal discharge + facial pain lasting ≥ 3–4 days

  3. Double sickening: worsening symptoms after initial improvement (after 5–6 days)

If none of these are present → Viral rhinosinusitis → treat supportively only.

4. Stepwise Management Approach

Stage 1: Viral / Early Non-Severe Sinusitis (Day 1–10)

🧠 “Supportive Care First”

A. Non-Pharmacologic Management

  1. Nasal saline irrigation

    • Isotonic (0.9%) preferred for daily use

    • Hypertonic (2–3%) short-term use for severe congestion

    • Clears mucus, allergens, and pathogens

    • Enhances steroid absorption

  2. Steam inhalation / humidified air→ Relieves congestion and sinus pressure

  3. Adequate hydration→ Thins mucus and improves drainage

  4. Rest and sleep hygiene

B. Pharmacologic Supportive Treatment

Medication

Example & Dose

Role

Intranasal corticosteroid

Budesonide (Bunase®) 1–2 sprays/nostril OD–BID

Reduces inflammation, edema, and congestion

Analgesic / Antipyretic

Paracetamol 500 mg q6h prn or Ibuprofen 400 mg tid pc

For facial pain, fever

Antihistamine (if allergic)

Loratadine 10 mg od or Cetirizine 10 mg od

For rhinorrhea, sneezing

Decongestant (short-term only)

Oxymetazoline spray bid ≤ 3 days

Opens nasal airway, avoid prolonged use (rebound rhinitis)

🩸 No antibiotic at this stage.

Stage 2: Bacterial Sinusitis Confirmed or Highly Suspected

🦠 “Start Antibiotic + Continue Supportive”

A. First-line Antibiotic Therapy

Drug

Dose

Duration

Remarks

Amoxicillin–Clavulanate

875/125 mg po bid pc

5–7 days

First choice (covers S. pneumoniae & H. influenzae)

Amoxicillin

1 g po tid pc

7–10 days

If low resistance risk

Doxycycline (if penicillin-allergic)

100 mg po bid

5–7 days

Alternative agent

Levofloxacin / Moxifloxacin

500 mg po qd

5 days

Reserve for resistant or recurrent cases

Avoid macrolides (Azithromycin, Clarithromycin) — due to high resistance of S. pneumoniae and H. influenzae.

B. Continue Adjunctive Therapies

  • Nasal saline irrigation (daily)

  • Intranasal corticosteroid (Budesonide / Mometasone)

  • Pain control with NSAIDs or acetaminophen

  • Antihistamines if allergic component present

Stage 3: Non-Responsive or Complicated Sinusitis

🏥 “Re-evaluate and escalate care”

If no improvement after 7 days of ATB or symptoms > 4 weeks:

  1. Reassess diagnosis – exclude dental origin or fungal sinusitis

  2. Obtain CT paranasal sinus for anatomical obstruction (In Thai, we order a film, PNS paranasal sinus)

  3. ENT referral for:

    • Nasal endoscopy

    • Possible sinus drainage or culture

  4. Consider a short-course oral corticosteroid if a nasal polyp is present

5. Chronic Rhinosinusitis (>12 weeks)

Usually inflammatory rather than infectious.Mainstay of treatment:

  • Intranasal corticosteroids daily

  • Saline irrigation

  • Treat underlying allergy/asthma

  • Antibiotics only if acute bacterial exacerbation

If persistent → CT scan → ENT evaluation for Functional Endoscopic Sinus Surgery (FESS)

6. Monitoring and Follow-up

Parameter

Time frame

Action

Mild viral case

7–10 days

Continue supportive care

Bacterial case on ATB

Reassess after 5–7 days

If no response → change antibiotic or ENT referral

Chronic / recurrent case

4–6 weeks

ENT assessment ± imaging

7. Patient Education

✅ Use nasal spray correctly (angle away from septum) ✅ Avoid using decongestant > 3 days ✅ Continue saline irrigation daily ✅ Complete full course of antibiotics ✅ Return if: fever > 39 °C, visual changes, periorbital swelling, or confusion

Clinical Pearls for Exams

  • >10 days or double sickening = Bacterial sinusitis

  • First-line antibiotic: Amoxicillin–Clavulanate

  • Saline + Steroid are foundation for all stages

  • Do not use macrolides or decongestants long-term

  • Chronic sinusitis → anti-inflammatory (steroid), not antibiotic


📚 References

  1. IDSA Guidelines for Acute Bacterial Rhinosinusitis in Adults and Children, Clin Infect Dis. 2021

  2. EPOS 2020: European Position Paper on Rhinosinusitis and Nasal Polyps

  3. Thai Clinical Practice Guideline for Rhinosinusitis (2022), Royal College of Otolaryngologists of Thailand

  4. CDC Sinus Infection Treatment Guidelines, 2023


Recent Posts

See All
Effect Size, MCID/CID, and Sample Size Relevance

1. Effect Size: The Foundation of Clinical Interpretation Effect size (ES) is the magnitude of difference or association  between groups, exposures, treatments, or predictors. It is the central compo

 
 
 

Comments

Rated 0 out of 5 stars.
No ratings yet

Add a rating
Post: Blog2_Post

​Message for International and Thai Readers Understanding My Medical Context in Thailand

Message for International and Thai Readers Understanding My Broader Content Beyond Medicine

bottom of page